Sihuan Pharmaceutical Holdings Group Ltd

Common Name
Sihuan Pharmaceutical
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,767
Ticker
460
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People'...

Sihuan Pharmaceutical's GHG Emissions Data Preview

In 2023, Sihuan Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Sihuan Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data

Verified Sources Behind Sihuan Pharmaceutical’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sihuan Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Sihuan Pharmaceutical's ESG Report 2023
a. Sihuan Pharmaceutical's ESG Report 2023
b. Sihuan Pharmaceutical's ESG Report 2022
b. Sihuan Pharmaceutical's ESG Report 2022

Insights into Sihuan Pharmaceutical's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Sihuan Pharmaceutical amounted to 104,067.67 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Sihuan Pharmaceutical decreased by 15.59%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Sihuan Pharmaceutical's Scope 1 Emissions Over Time

202120222023015 k30 k45 k60 ktCO2e+6%-13%
  • Total Scope 1
  • Year-over-Year Change

What are Sihuan Pharmaceutical's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Sihuan Pharmaceutical were 45,601.81 metric tons of CO₂ equivalent (tCO₂e). a

Has Sihuan Pharmaceutical reduced its Scope 1 emissions over time?

Since 2021, Sihuan Pharmaceutical's Scope 1 emissions have decreased by 7.55%, reflecting a declining long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2022), Sihuan Pharmaceutical's Scope 1 emissions decreased by 12.63%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Sihuan Pharmaceutical's Scope 2 emissions?

In 2023, Sihuan Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 58,465.86 tCO₂e without specifying the calculation method. a

Has Sihuan Pharmaceutical reduced its Scope 2 emissions over time?

Since 2021, Sihuan Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 20.45%, reflecting a declining long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2022), Sihuan Pharmaceutical's Scope 2 emissions (Unspecified Calculation Method) fell by 17.77% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a

What methodology does Sihuan Pharmaceutical use for Scope 2 reporting?

In 2023, Sihuan Pharmaceutical reported its Scope 2 emissions using an unspecified methodology. a

Sihuan Pharmaceutical's Scope 2 Emissions Over Time

202120222023020 k40 k60 k80 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Sihuan Pharmaceutical’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Sihuan Pharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 45,601.81 tCO₂e and total revenues of USD 286 millions. This translates into an emissions intensity of 159.27 tCO₂e per millions USD. a

Sihuan Pharmaceutical's Scope 1 Emissions Intensity Compared to Peers

102002,00050,000500,000Scope 1 Emissions (tCO2e)5502002,00010,000Revenues (Millions of USD)CCHPDDCSCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MHumanwell Healthcare GroupYear: 2023Scope 1: 23,403 tCO2eRevenue: $M 3,451Scope 1 Intensity: 6.78 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MHHHuadong MedicineYear: 2023Scope 1: 14,289 tCO2eRevenue: $M 5,716Scope 1 Intensity: 2.50 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYunnan Baiyao GroupYear: 2023Scope 1: 28,983 tCO2eRevenue: $M 5,503Scope 1 Intensity: 5.27 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MKingMed DiagnosticsYear: 2023Scope 1: 5,236 tCO2eRevenue: $M 1,202Scope 1 Intensity: 4.36 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$M

How does Sihuan Pharmaceutical's GHG emissions intensity compare to its peers?

In 2023, Sihuan Pharmaceutical reported a Scope 1 emissions intensity of 159.27 tCO₂e per millions USD. Compared to the peer group median of 25.27 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Sihuan Pharmaceutical rank on GHG emissions intensity within its industry?

In 2023, Sihuan Pharmaceutical ranked 26 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Sihuan Pharmaceutical among the least efficient performers, with one of the highest emissions intensities in its sector. a

Want Full Access to Sihuan Pharmaceutical's GHG Emissions Dataset?
Sign Up